Skip to content
10-Q

Quarterly Report

SBC Medical Group Holdings Incorporated SBC SBCWW

0001641172-25-023322

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 103.88M sh
Shares Diluted Q2 2025 · Jun 30, 2025 103.51M sh
Shares Diluted Q2 2025 · Jun 30, 2025 103.39M sh
Shares Diluted Q2 2025 · Jun 30, 2024 94.19M sh
Shares Diluted Q2 2025 · Jun 30, 2024 94.19M sh
Stock Repurchased Q2 2025 · Jun 30, 2025 $2.42M
Capex Q2 2025 · Jun 30, 2025 $560.43K
Capex Q2 2025 · Jun 30, 2024 $1.57M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$6.41M
Operating Cash Flow restated Q2 2025 · Jun 30, 2024 $22.87M
Long Term Debt Q2 2025 · Jun 30, 2025 $7.1M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $152.74M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $125.04M
Stockholders Equity Q2 2025 · Jun 30, 2025 $244.59M
Stockholders Equity Q2 2025 · Dec 31, 2024 $195.11M
Current Liabilities Q2 2025 · Jun 30, 2025 $60.68M
Current Liabilities Q2 2025 · Dec 31, 2024 $61.19M
Total Liabilities Q2 2025 · Jun 30, 2025 $70.65M
Total Liabilities Q2 2025 · Dec 31, 2024 $71.06M
Current Assets Q2 2025 · Jun 30, 2025 $241.34M
Current Assets Q2 2025 · Dec 31, 2024 $184.45M
Total Assets Q2 2025 · Jun 30, 2025 $315.3M
Total Assets Q2 2025 · Dec 31, 2024 $266.08M
Eps Diluted Q2 2025 · Jun 30, 2025 $0.02
Eps Diluted Q2 2025 · Jun 30, 2025 $0.23
Eps Diluted Q2 2025 · Jun 30, 2024 $0.20
Eps Diluted Q2 2025 · Jun 30, 2024 $0.40
Eps Basic Q2 2025 · Jun 30, 2025 $0.02
Eps Basic Q2 2025 · Jun 30, 2025 $0.23
Eps Basic Q2 2025 · Jun 30, 2024 $0.20
Eps Basic Q2 2025 · Jun 30, 2024 $0.40
Sga Expense Q2 2025 · Jun 30, 2025 $15.46M
Sga Expense Q2 2025 · Jun 30, 2025 $28.99M
Sga Expense Q2 2025 · Jun 30, 2024 $12.13M
Sga Expense Q2 2025 · Jun 30, 2024 $27.19M
Net Income Q2 2025 · Jun 30, 2025 $2.46M
Net Income Q2 2025 · Jun 30, 2025 $23.96M
Net Income restated Q2 2025 · Jun 30, 2024 $18.48M
Net Income restated Q2 2025 · Jun 30, 2024 $37.24M
Operating Income Q2 2025 · Jun 30, 2025 $14.55M
Operating Income Q2 2025 · Jun 30, 2025 $38.76M
Operating Income restated Q2 2025 · Jun 30, 2024 $27.29M
Operating Income restated Q2 2025 · Jun 30, 2024 $51.75M
Gross Profit Q2 2025 · Jun 30, 2025 $30.01M
Gross Profit Q2 2025 · Jun 30, 2025 $67.74M
Gross Profit Q2 2025 · Jun 30, 2024 $39.42M
Gross Profit Q2 2025 · Jun 30, 2024 $78.94M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $13.35M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $22.94M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $13.68M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $28.97M
Revenue Q2 2025 · Jun 30, 2025 $43.36M
Revenue Q2 2025 · Jun 30, 2025 $90.69M
Revenue Q2 2025 · Jun 30, 2024 $53.1M
Revenue Q2 2025 · Jun 30, 2024 $107.91M